TABLE 1.
Patient clinical characteristics
IC+RT arm | CCRT arm | p‐value | |
---|---|---|---|
Number | 99 | 99 | |
Age, years | 1 | ||
Median | 51 | 50 | |
Range | 22–68 | 24–68 | |
Gender | 1 | ||
Male | 75 | 75 | |
Female | 24 | 24 | |
Smoker | 60 | 68 | 0.234 |
Histology | 0.523 | ||
WHO Type II | 25 | 29 | |
WHO Type III | 74 | 70 | |
T classification a | 0.198 | ||
T1 | 10 | 20 | |
T2 | 14 | 16 | |
T3 | 50 | 44 | |
T4 | 25 | 19 | |
N classification a | 0.728 | ||
N0 | 6 | 4 | |
N1 | 17 | 13 | |
N2 | 54 | 56 | |
N3 | 22 | 26 | |
Staging a | 0.748 | ||
II | 2 | 1 | |
III | 53 | 57 | |
IVA | 44 | 41 |
Abbreviations: CCRT, concurrent chemoradiotherapy; IC, induction chemotherapy; RT, radiotherapy.
Patients were re‐staged according to the 8th edition of the UICC/AJCC staging system although only patients with stage III to IVB disease according to the 7th edition of the UICC/AJCC staging system were enrolled.